Your browser doesn't support javascript.
loading
Palliative Short-Course Radiation Therapy in Rectal Cancer: A Phase 2 Study.
Picardi, Vincenzo; Deodato, Francesco; Guido, Alessandra; Giaccherini, Lucia; Macchia, Gabriella; Frazzoni, Leonardo; Farioli, Andrea; Cuicchi, Dajana; Cilla, Savino; Cellini, Francesco; Uddin, A F M Kamal; Gambacorta, Maria Antonietta; Buwenge, Milly; Ardizzoni, Andrea; Poggioli, Gilberto; Valentini, Vincenzo; Fuccio, Lorenzo; Morganti, Alessio G.
Affiliation
  • Picardi V; Department of Radiotherapy, Fondazione di Ricerca e Cura "Giovanni Paolo II," Campobasso, Italy.
  • Deodato F; Department of Radiotherapy, Fondazione di Ricerca e Cura "Giovanni Paolo II," Campobasso, Italy.
  • Guido A; Radiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Giaccherini L; Radiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Macchia G; Department of Radiotherapy, Fondazione di Ricerca e Cura "Giovanni Paolo II," Campobasso, Italy. Electronic address: gmacchia@rm.unicatt.it.
  • Frazzoni L; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Farioli A; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Cuicchi D; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Cilla S; Department of Radiotherapy, Fondazione di Ricerca e Cura "Giovanni Paolo II," Campobasso, Italy.
  • Cellini F; Radiation Oncology Department, Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Uddin AF; Department of Radiation Oncology, United Hospital Limited, Dhaka, Bangladesh.
  • Gambacorta MA; Department of Radiotherapy, Policlinico Universitario "A. Gemelli," Università Cattolica del Sacro Cuore, Rome, Italy.
  • Buwenge M; Radiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Ardizzoni A; Medical Oncology Unit, Azienda Ospedaliera Universitaria, Policlinico S. Orsola-Malpighi, Bologna, Italy.
  • Poggioli G; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Valentini V; Department of Radiotherapy, Policlinico Universitario "A. Gemelli," Università Cattolica del Sacro Cuore, Rome, Italy.
  • Fuccio L; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Morganti AG; Radiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Int J Radiat Oncol Biol Phys ; 95(4): 1184-90, 2016 07 15.
Article in En | MEDLINE | ID: mdl-27215449
ABSTRACT

PURPOSE:

The management of patients with symptomatic rectal cancer not amenable to curative treatment may be challenging. The aim of this phase 2 study was to evaluate the efficacy of short-course radiation therapy in patients with obstructing rectal cancer. METHODS AND MATERIALS Patients who were not candidates for surgical resection because of synchronous metastases, age, and/or comorbidities were considered eligible. The sample size was calculated based on the 2-stage design of Simon. Short-course radiation therapy was delivered with an isocentric 4-field box technique (total, 25 Gy; 5 fractions in 5 days). Chemotherapy was suspended during radiation treatment. Clinical outcome measures were symptomatic response rate, toxicity, colostomy-free survival, and overall survival.

RESULTS:

From October 2003 to November 2012, 18 patients (median age, 77.5 years) were enrolled. The median follow-up was 11.5 months (range, 3-36 months). Four weeks after treatment, a complete response (ie, complete symptom resolution) was observed in 38.9% of patients and a partial response in 50.0% cases, whereas 11.1% had no response. The rates of reduction or resolution of pain and bleeding were 87.5% and 100%, respectively. The 1-, 2-, and 3-year colostomy-free survival rates were 100%, 71.4%, and 47.6%, respectively (median, 30 months). The 1-, 2-, and 3-year cumulative overall survival rates were 85.2%, 53%, and 39.8%, respectively (median, 25 months). No patients stopped treatment because of gastrointestinal or genitourinary toxicities 38.9% of patients had grade 1 to 2 toxicity, and 16.7% had grade 3 toxicity. Only 1 patient had hematologic grade 2 toxicity, and 2 patients had grade 2 skin toxicity.

CONCLUSIONS:

Short-course radiation therapy may represent a safe and effective alternative treatment option in patients with obstructing rectal cancer not eligible for curative treatment, allowing colostomy to be avoided in a substantial proportion of patients.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Palliative Care / Rectal Neoplasms Type of study: Etiology_studies / Observational_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2016 Document type: Article Affiliation country: Italia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Palliative Care / Rectal Neoplasms Type of study: Etiology_studies / Observational_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2016 Document type: Article Affiliation country: Italia